Most Recent
Regeneron, Bayer take fight over Eylea biosimilar to appeals court
Intellectual Property 2025-09-17 11:50 pm By Christine Caulfield

Biotech Regeneron and drug company Bayer have wasted no time in challenging a decision that cleared the way for generic pharmaceutical manufacturer Sandoz to launch a version of top selling Eylea.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?